Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
It has been suggested that the interaction of antipsychotic medications with neuronal nicotinic receptors may increase the cognitive dysfunction associated with schizophrenia and may explain why current therapies only partially address this core feature of the illness. In the present studies we compared the effects of the atypical antipsychotics quetiapine, clozapine and N-desmethylclozapine to those of the typical antipsychotics haloperidol and chlorpromazine on the alpha4beta2 and alpha7 nicotinic receptor subtypes. The binding of [(3)H]-nicotine to rat cortical alpha4beta2 receptors and [(3)H]-methyllycaconitine to rat hippocampal alpha7 receptors was not affected by any of the compounds tested. However, Rb(+) efflux evoked either by nicotine or the selective alpha4beta2 agonist TC-1827 from alpha4beta2 receptors expressed in SH-EP1 cells and nicotine-evoked [(3)H]-dopamine release from rat striatal synaptosomes were non-competitively inhibited by all of the antipsychotics. Similarly, alpha-bungarotoxin-sensitive epibatidine-evoked [(3)H]-norepinephrine release from rat hippocampal slices and acetylcholine-activated currents of alpha7 nicotinic receptors expressed in oocytes were inhibited by haloperidol, chlorpromazine, clozapine and N-desmethylclozapine. The inhibitory effects on nicotinic receptor function produced by the antipsychotics tested occurred at concentrations similar to plasma levels achieved in schizophrenia patients, suggesting that they may lead to clinically relevant effects on cognition.
Addy,
Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats.
2002, Pubmed
Addy,
Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats.
2002,
Pubmed
Aichhorn,
Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations.
2006,
Pubmed
Barnes,
Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use?
2006,
Pubmed
Bencherif,
The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors.
1998,
Pubmed
Bencherif,
Targeting neuronal nicotinic receptors: a path to new therapies.
2002,
Pubmed
Breese,
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia.
2000,
Pubmed
Champtiaux,
Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.
2003,
Pubmed
Chetty,
Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels.
1996,
Pubmed
Chetty,
Oral contraceptives increase the plasma concentrations of chlorpromazine.
2001,
Pubmed
Davies,
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?
2005,
Pubmed
Della Corte,
Pharmacokinetics of chlorimipramine, chlorpromazine and their N-dealkylated metabolites in plasma of healthy volunteers after a single oral dose of the parent compounds.
1993,
Pubmed
Diaz,
Plasma clozapine concentration coefficients of variation in a long-term study.
2005,
Pubmed
Dumortier,
Whole saliva and plasma levels of clozapine and desmethylclozapine.
1998,
Pubmed
Flanagan,
Comparability of whole-blood and plasma clozapine and norclozapine concentrations.
2003,
Pubmed
Freedman,
The genetics of sensory gating deficits in schizophrenia.
2003,
Pubmed
Freudenreich,
Monitoring of clozapine blood levels in the real world.
1996,
Pubmed
Friedman,
Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists.
2004,
Pubmed
Grimm,
Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.
2006,
Pubmed
Grinevich,
Heterologous expression of human {alpha}6{beta}4{beta}3{alpha}5 nicotinic acetylcholine receptors: binding properties consistent with their natural expression require quaternary subunit assembly including the {alpha}5 subunit.
2005,
Pubmed
Heidmann,
Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata.
1983,
Pubmed
Heidmann,
Characterization of the transient agonist-triggered state of the acetylcholine receptor rapidly labeled by the noncompetitive blocker [3H]chlorpromazine: additional evidence for the open channel conformation.
1986,
Pubmed
Hogg,
Nicotinic acetylcholine receptors: from structure to brain function.
2003,
Pubmed
Jozwiak,
Interaction of noncompetitive inhibitors with an immobilized alpha3beta4 nicotinic acetylcholine receptor investigated by affinity chromatography, quantitative-structure activity relationship analysis, and molecular docking.
2004,
Pubmed
Kumari,
Nicotine use in schizophrenia: the self medication hypotheses.
2005,
Pubmed
Lee,
Chlorpromazine-induced inhibition of catecholamine secretion by a differential blockade of nicotinic receptors and L-type Ca2+ channels in rat pheochromocytoma cells.
1999,
Pubmed
Leonard,
Smoking and mental illness.
2001,
Pubmed
Levin,
Acute and chronic nicotinic interactions with dopamine systems and working memory performance.
1995,
Pubmed
Levin,
Nicotine-haloperidol interactions and cognitive performance in schizophrenics.
1996,
Pubmed
Levin,
Chronic underactivity of medial frontal cortical beta2-containing nicotinic receptors increases clozapine-induced working memory impairment in female rats.
2009,
Pubmed
Levin,
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.
2006,
Pubmed
Levin,
Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.
2007,
Pubmed
Li,
N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.
2005,
Pubmed
Lin,
A liquid chromatographic-electrospray-tandem mass spectrometric method for quantitation of quetiapine in human plasma and liver microsomes: application to study in vitro metabolism.
2004,
Pubmed
Liu,
A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.
2009,
Pubmed
,
Xenbase
Luntz-Leybman,
Cholinergic gating of response to auditory stimuli in rat hippocampus.
1992,
Pubmed
Martin,
Schizophrenia and the alpha7 nicotinic acetylcholine receptor.
2007,
Pubmed
Marutle,
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia.
2001,
Pubmed
McEvoy,
Smoking in first-episode patients with schizophrenia.
1999,
Pubmed
Meltzer,
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
1999,
Pubmed
Moroni,
alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
2006,
Pubmed
,
Xenbase
Newhouse,
Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior.
1994,
Pubmed
Nguyen,
Effects of atypical antipsychotics on vertebrate neuromuscular transmission.
2002,
Pubmed
Papke,
Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.
2002,
Pubmed
,
Xenbase
Park,
Inhibition of nicotinic acetylcholine receptors and calcium channels by clozapine in bovine adrenal chromaffin cells.
2001,
Pubmed
Perry,
Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.
1991,
Pubmed
Pocivavsek,
Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats.
2006,
Pubmed
Roh,
Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients.
2001,
Pubmed
Sacco,
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.
2004,
Pubmed
Simosky,
Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice.
2001,
Pubmed
Simosky,
Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism.
2003,
Pubmed
Singhal,
Antipsychotic clozapine inhibits the function of alpha7-nicotinic acetylcholine receptors.
2007,
Pubmed
,
Xenbase
Stip,
[Cognition, schizophrenia and the effect of antipsychotics].
2006,
Pubmed
Tauscher-Wisniewski,
Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.
2002,
Pubmed
Terry,
Chronic exposure to typical or atypical antipsychotics in rodents: temporal effects on central alpha7 nicotinic acetylcholine receptors.
2005,
Pubmed
Wang,
Learning large-scale spatial relationships in a maze and effects of MK-801 on retrieval in the rhesus monkey.
2007,
Pubmed
Weiner,
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine.
2004,
Pubmed
Wong,
Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.
2006,
Pubmed
Young,
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice.
2007,
Pubmed
